Variation in Breast Cancer Risk Model Estimates Among Women in Their 40s Seen in Primary Care

被引:4
|
作者
Schonberg, Mara A. [1 ]
Karamourtopoulos, Maria [1 ]
Pinheiro, Adlin [1 ]
Davis, Roger B. [1 ]
Sternberg, Scot B. [1 ]
Mehta, Tejas S. [2 ]
Gilliam, Elizabeth A. [1 ]
Tung, Nadine M. [3 ]
机构
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med, Boston, MA 02446 USA
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Radiol, Div Breast Imaging, Boston, MA 02115 USA
[3] UMass Mem Med Ctr, UMass Mem Hlth, Dept Diagnost Imaging, Worcester, MA USA
关键词
mammography screening; women in 40s; breast cancer risk; VALIDATION; DENSITY;
D O I
10.1089/jwh.2021.0299
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The Gail, Breast Cancer Surveillance Consortium (BCSC), and Tyrer-Cuzick breast cancer risk prediction models are recommended for use in primary care. Calculating breast cancer risk is particularly important for women in their 40s when deciding on mammography, with some guidelines recommending screening for those with 5-year risk similar to women age 50 (>= 1.1%). Yet, little is known about risk estimate agreement among models for these women.Materials and Methods: Four hundred nine Boston-area women 40-49 years of age completed a risk questionnaire before a primary care visit to compute their breast cancer risk. The kappa statistic was used to examine when (1) Gail and BCSC agreed on 5-year risk >= 1.1%; (2) Gail estimated 5-year risk >= 1.7% and Tyrer-Cuzick estimated 10-year risk >= 5% (guideline thresholds for recommending prevention medications); and when (3) Gail and Tyrer-Cuzick agreed on lifetime risk >= 20% (threshold for breast MRI using Tyrer-Cuzick).Results: Participant mean age was 44.1 years, 56.7% were non-Hispanic white, and 7.8% had a first-degree relative with breast cancer. Of 266 with breast density information to estimate both Gail and BCSC, the models agreed on 5-year risk being >= 1.1% for 36 women, kappa = 0.34 (95% confidence interval: 0.23-0.45). Gail and Tyrer-Cuzick estimates led to agreement about prevention medications for 8 women, kappa 0.41 (0.20-0.61), and models agreed on lifetime risk >= 20% for 3 women, kappa 0.08 (-0.01 to 0.16).Conclusions: There is weak agreement on breast cancer risk estimates generated by risk models recommended for primary care. Using different models may lead to different clinical recommendations for women in their 40s.
引用
收藏
页码:495 / 502
页数:8
相关论文
共 50 条
  • [1] PERSONALIZING BREAST CANCER SCREENING AND PREVENTION IN WOMEN IN THEIR 40S SEEN IN PRIMARY CARE
    Schonberg, Mara
    Karamourtopoulos, Maria
    Pinheiro, Adlin
    Sternberg, Scot B.
    Davis, Roger
    Mehta, Tejas S.
    Cohen, Marc
    Beach, Jennifer
    Tung, Nadine
    [J]. MEDICAL DECISION MAKING, 2020, 40 (01) : E162 - E162
  • [2] Screening for breast cancer among women in their 40s
    Kopans, Daniel B.
    [J]. LANCET ONCOLOGY, 2010, 11 (12): : 1108 - 1109
  • [4] Breast cancer screening for women in their 40s reduces mortality
    不详
    [J]. CANCER, 2021, 127 (04): : 497 - 497
  • [5] News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer
    Schwartz, LM
    Woloshin, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (23): : 3136 - 3142
  • [6] To Screen or Not to Screen Women in Their 40s for Breast Cancer: Is Personalized Risk-Based Screening the Answer?
    Mandelblatt, Jeanne S.
    Stout, Natasha
    Trentham-Dietz, Amy
    [J]. ANNALS OF INTERNAL MEDICINE, 2011, 155 (01) : 58 - +
  • [7] A Pre-Test-Post-Test Trial of a Breast Cancer Risk Report for Women in Their 40s
    Schonberg, Mara A.
    Davis, Roger B.
    Karamourtopoulos, Maria C.
    Pinheiro, Adlin
    Sternberg, Scot B.
    Jacobson, Alicia R.
    Aliberti, Gianna M.
    Mehta, Tejas S.
    Cluett, Jennifer L.
    Cohen, Marc L.
    Atlas, Tobie
    Tung, Nadine M.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2020, 59 (03) : 343 - 354
  • [8] Body mass index and breast cancer risk of women in their 40s: Systematic review and meta-analysis
    Cantor, Amy Gabrielle
    Fu, Rongwei
    Zakher, Bernadette
    Griffin, Jessica
    Nelson, Heidi
    [J]. JOURNAL OF WOMENS HEALTH, 2012, 21 (04) : 9 - 9
  • [9] Women in their 40s should not be screened for breast cancer, new Canadian guideline says
    O'Dowd, Adrian
    [J]. BRITISH MEDICAL JOURNAL, 2011, 343
  • [10] THE BIOLOGY OF BREAST-CANCER IN THE UNDER 40S
    SAINSBURY, R
    [J]. PATHOLOGIE BIOLOGIE, 1991, 39 (09): : 839 - 839